MADISON JAMES: Open Payments
NPI 1306439112 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 45 payments from 12 companies in 2025. Trend: 2023 $40 · 2024 $593 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $226 |
| PFIZER INC. | 11 | $160 |
| Axsome Therapeutics, Inc. | 4 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Lilly USA, LLC | 3 | $51 |
| Lundbeck LLC | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Novo Nordisk Inc | 2 | $32 |
| ABBVIE INC. | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: REXULTI, Auvelity, NURTEC ODT, ELIQUIS, CAPLYTA, MOUNJARO, BREZTRI, AIRSUPRA.
Industry payments across MS — which companies pay providers there.
